<strong>Report</strong> <strong>of</strong> the Commission on Financial Management <strong>and</strong> Control Systems in the <strong>Health</strong> Servicerecovered by setting it against payments due to the GP in the following year.Recommendations in respect <strong>of</strong> the General Medical Service (cont’d)R6.8 GPs should be assigned responsibility for reporting to the health board on the accuracy <strong>of</strong> their list <strong>of</strong>registered medical cardholders annually.R6.9 <strong>Health</strong> boards should introduce new verification <strong>and</strong> audit procedures to ensure their lists <strong>of</strong> medicalcardholders are accurate.R6.10 Based on an evaluation <strong>of</strong> the reports at R6.8 by the health board, overpayments made in a previous year (forexample, where a patient dies or moves to another GP) should be automatically netted <strong>of</strong>f by the health boardagainst that GP’s Practice Budget for the following year.6.4 COMMUNITY DRUG SCHEMESThe main community drugs schemes are prescriptions under the medical card scheme, asdescribed in the preceding section, <strong>and</strong> the Drugs Payment Scheme (DPS). There are morespecialised schemes namely the Long Term Illness Scheme (for certain defined illnesses/conditions) <strong>and</strong> High Tech Medicines Scheme (for certain high cost drug products).Medical Card Scheme: provision <strong>of</strong> drugs, medicines <strong>and</strong> appliancesA medical cardholder is entitled to free drugs, medicines <strong>and</strong> appliances, as prescribed byhis/her GP, chosen from a list <strong>of</strong> 4,536 licensed drugs, medicines <strong>and</strong> appliances, agreed betweenthe <strong>Department</strong> <strong>of</strong> <strong>Health</strong> <strong>and</strong> <strong>Children</strong> <strong>and</strong> the Irish Pharmaceutical <strong>Health</strong>care Association.This list includes products <strong>of</strong> similar content but <strong>of</strong> (sometimes substantially) varying cost.The retail pharmacist filling a prescription is entitled to a dispensing fee <strong>and</strong>reimbursement for the drugs, medicines <strong>and</strong> appliances dispensed on a cost <strong>of</strong> ingredients basis.We underst<strong>and</strong> that, in accordance with normal commercial practice, retail pharmacies routinelynegotiate discounts (in the form <strong>of</strong> rebates) with wholesalers in relation to the products theyprovide under the medical card scheme.In all health board areas, on a voluntary basis, GPs are participating in initiatives designed tocontain prescribing costs. In the case <strong>of</strong> the Indicative Drug Target Savings Scheme, operatingsince 1993, this has involved setting a nominal drugs budget for the GP practice based on his/hernumber <strong>of</strong> patients with medical cards <strong>and</strong> average prescribing rates for the country as a whole.Savings made under the scheme are made available by the health board for investment in thedevelopment <strong>of</strong> general practice (including infrastructure, equipment <strong>and</strong> computer costs).In at least one health board area, we are aware that savings under this initiative have been usedto co-fund the construction <strong>and</strong> equipping <strong>of</strong> a number <strong>of</strong> local health centres owned by thehealth board where the GP is a central figure within the team providing services from thecentre. Significant investment in medical equipment, communications <strong>and</strong> computer systems forprimary care has also been achieved. This is fully in accordance with Government strategy onprimary care. The use <strong>of</strong> resources under the scheme may <strong>of</strong>fer important lessons for use in awider context.80
Chapter 6 Accountability – General Medical Services <strong>and</strong> Community Drug SchemesDrugs Payment SchemeUnder the Drugs Payment Scheme, individuals <strong>and</strong> families pay only the first ¤ 70 per calendarmonth <strong>of</strong> expenditure on approved items. Under the scheme, GPs, Consultants <strong>and</strong> Dentistsmay prescribe approved medicines <strong>of</strong> their choice from a list <strong>of</strong> licensed drugs, medicines <strong>and</strong>appliances, agreed between the <strong>Department</strong> <strong>of</strong> <strong>Health</strong> <strong>and</strong> <strong>Children</strong> <strong>and</strong> the IrishPharmaceutical <strong>Health</strong>care Association. This list includes the 4,536 items from themedical card list above plus a further 3,673 items. It should, however, be noted that, in 2002,only 2.4% <strong>of</strong> the drugs prescribed/dispensed under the Drugs Payment Scheme (at a cost <strong>of</strong>¤ 5.8 million) were from this supplementary list.The retail pharmacist facilitating this service is entitled to a dispensing fee <strong>and</strong> a 50% mark upon the ingredient costs <strong>of</strong> the products dispensed. Again, it is understood that, in accordancewith normal commercial practice, retail pharmacies routinely negotiate discounts (in the form<strong>of</strong> rebates) with wholesalers in relation to the drugs, medicines <strong>and</strong> appliances they supply underthe Drugs Payment Scheme.As Figure 6.1 below suggests, the cost <strong>of</strong> operating these publicly-funded drugs schemes hasincreased significantly in recent years.Figure 6.1: Comparative Costs <strong>of</strong> Publicly-Funded Pharmacy Services, 2001 - 2003Cost <strong>of</strong> Services (£ m)800700600200120022003 (est)5004003002001000GMS:DoctorsGMS:PharmacyClaimsGMS:HighTechDPS:PharmacyClaimsLTI:PharmacyClaimsDPS:HighTechSource: GMS (Payments) BoardAccording to the 2001 Annual <strong>Report</strong> <strong>of</strong> the GMS (Payments) Board, the national averagepharmacy cost per medical card holder was ¤ 371. The national average pharmacy cost perclaimant under the Drugs Payment Scheme (DPS), was ¤ 890, not including the co-paymentcontribution per claimant (the gross figure is ¤ 1,314). As such, the pharmacy costs <strong>of</strong> the twomain publicly-funded schemes, the medical card <strong>and</strong> the Drugs Payment Scheme, varyconsiderably.81